Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000506789 | SCV000602325 | benign | not specified | 2017-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001704658 | SCV000729291 | likely benign | not provided | 2020-08-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000653968 | SCV000775858 | benign | Charcot-Marie-Tooth disease type 2 | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002461263 | SCV002755351 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000506789 | SCV005394996 | likely benign | not specified | 2024-09-10 | criteria provided, single submitter | clinical testing | Variant summary: AARS1 c.1632C>T alters a non-conserved nucleotide resulting in a synonymous change. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00034 in 282878 control chromosomes in the gnomAD database, including 2 homozygotes. To our knowledge, no occurrence of c.1632C>T in individuals affected with Developmental and epileptic encephalopathy, 29 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 439344). Based on the evidence outlined above, the variant was classified as likely benign. |
Prevention |
RCV003960193 | SCV004768744 | likely benign | AARS1-related disorder | 2019-02-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |